Skip to main content
Print

Medications for Pancreatic Cancer

Other names: Cancer, Pancreas; Cancer, Pancreatic; Pancreatic Carcinoma

Pancreatic carcinoma is a malignancy (cancer) of the pancreas.

Drugs used to treat Pancreatic Cancer

The following list of medications are in some way related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
gemcitabine 8.0 4 reviews
Rx D N

Generic name: gemcitabine systemic

Brand names:  Gemzar, Infugem

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Afinitor 9.0 1 review
Rx D N

Generic name: everolimus systemic

Drug class: mTOR inhibitors, selective immunosuppressants

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Gemzar 8.0 4 reviews
Rx D N

Generic name: gemcitabine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

fluorouracil Rate Add review
Rx D N

Generic name: fluorouracil systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Abraxane 1.0 1 review
Rx D N

Generic name: paclitaxel protein-bound systemic

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

capecitabine Off-label 1.0 2 reviews
Rx D N

Generic name: capecitabine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Off-label: Yes

methotrexate Off-label Rate Add review
Rx X N X

Generic name: methotrexate systemic

Drug class: antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Off-label: Yes

bevacizumab Off-label 9.0 1 review
Rx C N

Generic name: bevacizumab systemic

Drug class: VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

Off-label: Yes

Tarceva 6.0 2 reviews
Rx D N

Generic name: erlotinib systemic

Drug class: EGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Sutent 5.0 2 reviews
Rx D N

Generic name: sunitinib systemic

Drug class: multikinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

everolimus 9.0 1 review
Rx D N

Generic name: everolimus systemic

Brand name:  Afinitor

Drug class: mTOR inhibitors, selective immunosuppressants

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

pancreatin Off-label Rate Add review
Rx/OTC C N

Generic name: pancreatin systemic

Drug class: digestive enzymes

For consumers: interactions, side effects

Off-label: Yes

paclitaxel protein-bound 5.0 2 reviews
Rx D N

Generic name: paclitaxel protein-bound systemic

Brand name:  Abraxane

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

irinotecan liposomal Rate Add review
Rx N

Generic name: irinotecan liposomal systemic

Brand name:  Onivyde

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

Onivyde Rate Add review
Rx N

Generic name: irinotecan liposomal systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

Zanosar Rate Add review
Rx D N

Generic name: streptozocin systemic

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

erlotinib 5.7 3 reviews
Rx D N

Generic name: erlotinib systemic

Brand name:  Tarceva

Drug class: EGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Mutamycin Rate Add review
Rx N N

Generic name: mitomycin systemic

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

sunitinib 5.0 2 reviews
Rx D N

Generic name: sunitinib systemic

Brand name:  Sutent

Drug class: multikinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

olaparib 1.0 1 review
Rx D N

Generic name: olaparib systemic

Brand name:  Lynparza

Drug class: PARP inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

cetuximab Off-label Rate Add review
Rx C N

Generic name: cetuximab systemic

Drug class: EGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

Off-label: Yes

Lynparza 1.0 1 review
Rx D N

Generic name: olaparib systemic

Drug class: PARP inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

mitomycin Rate Add review
Rx N N

Generic name: mitomycin systemic

Brand name:  Mutamycin

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

streptozocin Rate Add review
Rx D N

Generic name: streptozocin systemic

Brand name:  Zanosar

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

Infugem Rate Add review
Rx D N

Generic name: gemcitabine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Frequently asked questions

View more FAQ

Learn more about Pancreatic Cancer

Care guides

Symptoms and treatments

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer